Proximagen Group plc

While over 270 companies are doing artificial intelligence-driven drug development, many potential partners and investors are holding out for the first fruits of AI-based approaches. However, Benevol

The US Food and Drug Administration has a dozen user fee goal dates for pending applications coming up in June, according to the Pink Sheet’s US FDA Performance Tracker. The majority of the applicatio

Industry channeled its inner Scott Gottlieb during the outgoing commissioner's final week as head of the agency by unleashing a barrage of drug development announcements. Here's your news in brief: P

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c